WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

A REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON OMICRON VARIANTA REVIEW ON

Vikas Bodhak*, Gayatri Dhonde, Rohini Gambhire, Pravin Bhavar, Om Bodkhe, Yash Deshmukh, Harish Dhokne, Aaditya Dhonde, Samadhan Dindore, Sanjay Gaikwad and Rahul Galgate

ABSTRACT

The Omicron variant is a variant of SARS-CoV-2, the virus that causes COVID-19. As of December 2021, it is the newest variant. It was first reported to the World Health Organization (WHO) from South Africa on 24 November 2021. On 26 November 2021, the WHO designated it as a variant of concern and named it "Omicron", the fifteenth letter in the Greek alphabet. The variant has an unusually large number of mutations, several of which are novel (see ยง Mutations) and a significant number of which affect the spike protein targeted by most COVID-19 vaccines at the time of discovering the Omicron variant. This level of variation has led to concerns regarding its transmissibility, immune system evasion, and vaccine resistance, despite initial reports indicating that the variant causes less serious disease than previous strains. The variant was quickly designated as being "of concern", and travel restrictions were introduced by several countries in an attempt to slow its international spread. The Omicron can be classified into the different types such as, Variant Being Monitored (VBM) Alpha (B.1.1.7 and Q lineages, Beta (B.1.351 and descendent lineages), Gamma (P.1 and descendent lineages), Epsilon (B.1.427 and B.1.429), Eta (B.1.525), Iota (B.1.526), Kappa (B.1.617.1), Mu (B.1.621, B.1.621.1), Zeta (P.2), Variant of Interest (VOI), Variant of Concern (VOC), Delta (B.1.617.2 and AY lineages), Omicron (B.1.1.529 and BA lineages), Variant of High Consequence (VOHC). In this review article include the causes, symptoms and transmissions, of the omicron variant and also include the treatments, prevention of the omicron virus.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More